Andrew R Coggan1, Joshua L Leibowitz2, Catherine Anderson Spearie2, Ana Kadkhodayan2, Deepak P Thomas2, Sujata Ramamurthy2, Kiran Mahmood2, Soo Park2, Suzanne Waller2, Marsha Farmer2, Linda R Peterson2. 1. From the Cardiovascular Imaging Laboratory, Division of Radiological Sciences, Department of Radiology (A.R.C., J.L.L., L.R.P.), Cardiovascular Division, Department of Medicine (J.L.L., A.K., D.P.T., S.R., K.M., S.P., M.F., L.R.P.), and Center for Applied Research Sciences (C.A.S.), Washington University School of Medicine, St. Louis, MO. coggana@mir.wustl.edu. 2. From the Cardiovascular Imaging Laboratory, Division of Radiological Sciences, Department of Radiology (A.R.C., J.L.L., L.R.P.), Cardiovascular Division, Department of Medicine (J.L.L., A.K., D.P.T., S.R., K.M., S.P., M.F., L.R.P.), and Center for Applied Research Sciences (C.A.S.), Washington University School of Medicine, St. Louis, MO.
Abstract
BACKGROUND:Skeletal muscle strength, velocity, and power are markedly reduced in patients with heart failure, which contributes to their impaired exercise capacity and lower quality of life. This muscle dysfunction may be partially because of decreased nitric oxide (NO) bioavailability. We therefore sought to determine whether ingestion of inorganic nitrate (NO3 (-)) would increase NO production and improve muscle function in patients with heart failure because of systolic dysfunction. METHODS AND RESULTS: Using a double-blind, placebo-controlled, randomized crossover design, we determined the effects of dietary NO3 (-) in 9 patients with heart failure. After fasting overnight, subjects drank beetroot juice containing or devoid of 11.2 mmol of NO3 (-). Two hours later, muscle function was assessed using isokinetic dynamometry. Dietary NO3 (-) increased (P<0.05-0.001) breath NO by 35% to 50%. This was accompanied by 9% (P=0.07) and 11% (P<0.05) increases in peak knee extensor power at the 2 highest movement velocities tested (ie, 4.71 and 6.28 rad/s). Maximal power (calculated by fitting peak power data with a parabola) was therefore greater (ie, 4.74±0.41 versus 4.20±0.33 W/kg; P<0.05) after dietary NO3 (-) intake. Calculated maximal velocity of knee extension was also higher after NO3 (-) ingestion (ie, 12.48±0.95 versus 11.11±0.53 rad/s; P<0.05). Blood pressure was unchanged, and no adverse clinical events occurred. CONCLUSIONS: In this pilot study, acute dietary NO3 (-) intake was well tolerated and enhanced NO bioavailability and muscle power in patients with systolic heart failure. Larger-scale studies should be conducted to determine whether the latter translates into an improved quality of life in this population. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01682356.
RCT Entities:
BACKGROUND: Skeletal muscle strength, velocity, and power are markedly reduced in patients with heart failure, which contributes to their impaired exercise capacity and lower quality of life. This muscle dysfunction may be partially because of decreased nitric oxide (NO) bioavailability. We therefore sought to determine whether ingestion of inorganic nitrate (NO3 (-)) would increase NO production and improve muscle function in patients with heart failure because of systolic dysfunction. METHODS AND RESULTS: Using a double-blind, placebo-controlled, randomized crossover design, we determined the effects of dietary NO3 (-) in 9 patients with heart failure. After fasting overnight, subjects drank beetroot juice containing or devoid of 11.2 mmol of NO3 (-). Two hours later, muscle function was assessed using isokinetic dynamometry. Dietary NO3 (-) increased (P<0.05-0.001) breath NO by 35% to 50%. This was accompanied by 9% (P=0.07) and 11% (P<0.05) increases in peak knee extensor power at the 2 highest movement velocities tested (ie, 4.71 and 6.28 rad/s). Maximal power (calculated by fitting peak power data with a parabola) was therefore greater (ie, 4.74±0.41 versus 4.20±0.33 W/kg; P<0.05) after dietary NO3 (-) intake. Calculated maximal velocity of knee extension was also higher after NO3 (-) ingestion (ie, 12.48±0.95 versus 11.11±0.53 rad/s; P<0.05). Blood pressure was unchanged, and no adverse clinical events occurred. CONCLUSIONS: In this pilot study, acute dietary NO3 (-) intake was well tolerated and enhanced NO bioavailability and muscle power in patients with systolic heart failure. Larger-scale studies should be conducted to determine whether the latter translates into an improved quality of life in this population. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01682356.
Authors: Stuart D Katz; Katarzyna Hryniewicz; Ingrid Hriljac; Kujtim Balidemaj; Clarito Dimayuga; Alhakam Hudaihed; Aleksandr Yasskiy Journal: Circulation Date: 2005-01-17 Impact factor: 29.690
Authors: E Clini; M Volterrani; M Pagani; L Bianchi; R Porta; L S Gile'; A Giordano; N Ambrosino Journal: Int J Cardiol Date: 2000-04-28 Impact factor: 4.164
Authors: David R Morgan; Lana J Dixon; Colm G Hanratty; Sinead M T Hughes; William J Leahey; Keith P Rooney; G Dennis Johnston; Gary E McVeigh Journal: Eur J Heart Fail Date: 2004-12 Impact factor: 15.534
Authors: Andrew R Coggan; Richard L Hoffman; Derrick A Gray; Ranjani N Moorthi; Deepak P Thomas; Joshua L Leibowitz; Dakkota Thies; Linda R Peterson Journal: J Gerontol A Biol Sci Med Sci Date: 2020-05-22 Impact factor: 6.053
Authors: Carl D Koch; Mark T Gladwin; Bruce A Freeman; Jon O Lundberg; Eddie Weitzberg; Alison Morris Journal: Free Radic Biol Med Date: 2016-12-16 Impact factor: 7.376
Authors: Payman Zamani; Victor Tan; Haideliza Soto-Calderon; Melissa Beraun; Jeffrey A Brandimarto; Lien Trieu; Swapna Varakantam; Paschalis-Thomas Doulias; Raymond R Townsend; Jesse Chittams; Kenneth B Margulies; Thomas P Cappola; David C Poole; Harry Ischiropoulos; Julio A Chirinos Journal: Circ Res Date: 2016-12-07 Impact factor: 17.367
Authors: Andrew R Coggan; Seth R Broadstreet; Kiran Mahmood; Deana Mikhalkova; Michael Madigan; Indra Bole; Soo Park; Joshua L Leibowitz; Ana Kadkhodayan; Deepak P Thomas; Dakkota Thies; Linda R Peterson Journal: J Card Fail Date: 2017-09-12 Impact factor: 5.712
Authors: Payman Zamani; Benjamin French; Jeffrey A Brandimarto; Paschalis-Thomas Doulias; Ali Javaheri; Julio A Chirinos; Kenneth B Margulies; Raymond R Townsend; Nancy K Sweitzer; James C Fang; Harry Ischiropoulos; Thomas P Cappola Journal: Am J Cardiol Date: 2016-09-15 Impact factor: 2.778
Authors: Stephen J Carter; Allison H Gruber; John S Raglin; Marissa N Baranauskas; Andrew R Coggan Journal: Med Hypotheses Date: 2020-04-09 Impact factor: 1.538
Authors: Scott K Ferguson; Clark T Holdsworth; Trenton D Colburn; Jennifer L Wright; Jesse C Craig; Alex Fees; Andrew M Jones; Jason D Allen; Timothy I Musch; David C Poole Journal: J Appl Physiol (1985) Date: 2016-07-21